Embolization Coils Market Share

North American Market Forecast

Embolization coils market in North America is predicted to account for the largest share of 41% by 2035 impelled by the growing spending in healthcare. As a result, more advanced smart diagnostic and monitoring medical device such as embolization coils are being developed in the region. This has increased the adoption rates of these coils as they have become more accessible to people and are easily available in hospitals and clinics. In 2021, the United States spent over 2% more on health care.

European Market Statistics

The Europe embolization coils market is estimated to be the second largest, during the forecast timeframe led by increasing cases of cardiac aneurysm. This is expected to increase the demand for an embolization coils in the region as it is used to treat aneurysms, which involves filling the sac with material to prevent bleeding and closing it off. Each year, more than 14,000 Americans and over 25,000 Europeans are diagnosed with ascending thoracic aortic aneurysm (ATAA).

Frequently Asked Questions (FAQ)

Growing cases of cancer across the globe and the growing usage in hematuria management are the major factors driving the growth of the market.

The market size of Embolization Coils is anticipated to attain a CAGR of 6% over the forecast period, i.e., 2023 â€“ 2035.

The major players in the market are Boston Scientific Corporation, Stryker Corporation, DePuy Synthes, Medtronic, St. Jude Medical.

The detachable coil segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

Embolization Coils Market Share